Ishami Mpuzamahanga

Ku itariki ya 3 Ukuboza 2024, umuti mushya witwa Zepzelca (lurbinectin yo guterwa inshinge) wemejwe n'Ikigo cy'Igihugu cy'Ubushinwa gishinzwe Ibikoresho by'Ubuvuzi (NMPA) binyuze muri gahunda yo gusuzuma ibyihutirwa. Uyu muti ugenewe kuvura abarwayi bakuru bafite uturemangingo duto tw'ibihaha ...Soma byinshi»

Ku itariki ya 31 Ukuboza, Ikigo cy’Igihugu gishinzwe Ibikoresho by’Ubuvuzi mu Bushinwa (NMPA) cyemeje VYLOYTM (zolbetuximab), hamwe na fluoropyrimidine na platine irimo imiti ya chimiotherapie, mu rwego rwo kuvura abarwayi bafite indwara y’uruhu rw’imbere mu mubiri w’umuntu idakira cyangwa ikwirakwira mu mikurire y’uruhu rw’imbere mu mubiri we...Soma byinshi»

Ku ya 31 Ukuboza 2024, Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. ("Isosiyete") yahawe uburenganzira bwo kwamamaza mu Bushinwa buturutse ku Kigo cy’Igihugu gishinzwe Ibikoresho by’Ubuvuzi (NMPA) ku ikoreshwa ry’uturemangingo tw’umubiri duto (antibody) twa monoclonal twateguwe n’umuntu (“mAb”) tagitanlim...Soma byinshi»

C-CAR031 ni uburyo bwo kuvura bwa GPC3-targeting chimeric antigen receptor T-Seli (CAR-T) bukoreshwa mu kuvura HCC. Bushingiye ku buryo bushya bwa GPC3-targeting CAR-T bwakozwe na AstraZeneca bukoresheje igikoresho cyabo cya dominant negative transforming growth factor-beta receptor II dominant negati...Soma byinshi»

Ku ya 20 Ukuboza 2024, Ikigo cy’Igihugu gishinzwe Ibikoresho by’Ubuvuzi mu Bushinwa (NMPA) cyemeje Porogaramu Nshya y’Imiti (NDA) ya DOVBLERON ® (taletrectinib adipate capsule), ikoreshwa mu kuvura abarwayi bakuru bafite ROS yateye imbere cyangwa yanduye mu gace runaka...Soma byinshi»

C-CAR031 ni uburyo bwo kuvura bwa GPC3-target chimeric antigen receptor T-Seli (CAR-T) bukoreshwa mu kuvura HCC. Ubushakashatsi bwa C-CAR031 ku ndwara ya kanseri y'umwijima (HCC) bwatanzwe mu magambo mu nama ngarukamwaka y'Umuryango w'Abanyamerika wita ku ndwara ya kanseri (ASCO) ...Soma byinshi»

GT101 ni uburyo bwo kuvura uturemangingo tw’umubiri bukozwe muri TIL yagutse kandi ivuguruye iva mu kibyimba cy’umurwayi ubwe. Ubu buryo butangwa hifashishijwe gukuramo ingirangingo z’ikibyimba mu barwayi hanyuma hagakurwamo TIL. Hanyuma TIL yakuwemo izamurwa hakoreshejwe urubuga rwa Grit Bio rukora StemTe...Soma byinshi»

Uturemangingo twa TAEST16001 ni uturemangingo twa T twitwa autologous turemangingo twitwa NY-ESO-1-specific T-cell receptor (TCR) twibasira NY-ESO-1 (igaragara mu tumori twinshi) positive soft tissue sarcoma (STS) mu rwego rwa HLA-A*02:01. Inyigo y'icyiciro cya mbere ku barwayi bafite S...Soma byinshi»

Ku itariki ya 04 Ukuboza 2024, hashyizweho uburyo bushya bwo kuvura abarwayi ba kanseri y’inkondo y’umura (NDA) ivanze na TYVYT® (sintilimab injection) na ELUNATE® (fruquintinib) mu Bushinwa, bugenewe kuvura abarwayi bafite kanseri y’inkondo y’umura ifite ibibyimba bya Mismatch Repair proficient (pMMR) bifite ...Soma byinshi»

GC203 ni uburyo bushya bwo kuvura bwa TIL butari virusi bwakozwe hifashishijwe urubuga rwo kwagura utunyangingo twa Juncell Therapeutics rwa DeepTIL® hamwe na urubuga rwo guhindura utunyangingo rwa NovaGMP®. DeepTIL® ituma TILs zikora neza ku buryo nta IL-2 ikenewe nyuma yo kuyitera,...Soma byinshi»

Glioblastoma Multiforme (GBM) ni imwe muri kanseri zica cyane, kandi hafi ya bose abarwayi basubira kurwara GBM ukurikije uburyo busanzwe bwo kwivuza. GBM isubiramo (rGBM) igaragaza ko umuntu adashobora kubaho amezi 8 ariko nta buryo bwinshi bwo kuyivura. TX103 ni kanseri ya CAR-T...Soma byinshi»

RD13-02 ni selile za CAR-T zikoreshwa ku isi hose zigamije CD7 zikomoka ku baterankunga bazima, kandi zigenewe kuvura kanseri y’amaraso ya T-cell acute lymphoblastic leukemia/lymphoma (T-ALL/LBL) yasubiwemo cyangwa idashobora kugaragara. Yahinduwe mu buryo bw’uturemangingo kugira ngo hirindwe fratricide, indwara ya graft-versus-host (GvHD), na host-versus-...Soma byinshi»